Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Entero Therapeutics ( (ENTO) ).
On July 3, 2025, Entero Therapeutics, Inc. received a notification from Nasdaq confirming that the company has regained compliance with the Nasdaq Listing Rule 5620(a) following its Annual Meeting on June 30, 2025. This resolution closes the compliance matter, potentially stabilizing the company’s market position and reassuring stakeholders of its adherence to regulatory requirements.
More about Entero Therapeutics
Average Trading Volume: 1,255,647
Technical Sentiment Signal: Strong Sell
Current Market Cap: $1.89M
Learn more about ENTO stock on TipRanks’ Stock Analysis page.